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The association of novel polymorphisms with Stress Fracture Injury in Elite Athletes: 
Further insight into the SFEA cohort. 
 
 
Abstract  
Objective: To determine, in conjunction with a wider investigation, whether 11 genetic 
variants in the vicinity vitamin D, collagen and Wnt signalling pathways were associated with 
stress fracture injury in the Stress Fracture Elite Athlete (SFEA) cohort.  
Design: Genotype-phenotype association study.  
Method: Self-reported stress fracture history and demographic data were recorded in 518 elite 
athletes, 449 male and 69 female (mean age 24.2±5.5 y) from the SFEA cohort. Elite athletes 
were assigned to two groups based on history stress fracture injury. Data were analysed for 
the whole cohort and sub-stratified in male only and multiple stress fracture cases. Genotype 
was determined using a proprietary fluorescence-based competitive allele-specific 
polymerase chain reaction assay. 
Results: SOST SNP rs1877632 and VDR SNPs rs10735810 and rs731236 were associated 
with stress fracture (p<0.05). In the whole cohort, rs1877632 heterozygotes and homozygotes 
of the rare allele combined made up 59% of stress fracture sufferers in comparison to 46% in 
the non-stress fracture group (p=0.05). In the multiple stress fracture cohort, homozygotes of 
the rare allele of  rs10735810 and rs731236 showed an association with stress fracture when 
compared to those homozygotes for the common allele combined with heterozygotes (p= 
0.03; p=0.01). No significant associations were shown in the other SNPs analysed (p>0.05).      
Conclusions: These data suggest an important role for SOST SNP rs1877632 and VDR SNPs 
rs10735810 and rs731236 in the pathophysiology of stress fracture. This might be due to the 
role of the SNPs in the regulation of bone remodelling and adaptation to mechanical loading, 
with  potential implications for the prevention and treatment of stress fracture. 
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Introduction  
Stress fracture injuries are caused by mechanical loading that is applied in a rhythmic, 
repeated, sub-threshold manner (1), although the exact pathophysiology is not fully 
understood (2).  The high volume, intensity and type of training that is required to be 
successful in elite sport makes athletes in body weight loaded sports  particularly susceptible 
to sustaining this type of injury (3). 
Stress fracture injuries account for 0.7%-20% of all athletic sports injuries (Bennell et al., 
1997; Fredericson et al., 2006), cause significant discomfort, result in a prolonged loss of 
training time (Ranson et al., 2010) and can have a significant detrimental financial effect on 
the athlete and/or the club/organisation. The pathophysiology of stress fracture is complex (4) 
including, but not limited to risk factors such as: the female athlete triad (Barrack et al 2014), 
unaccustomed or excessive exercise (5), nutritional deficiencies (6), previous stress fracture 
(Tenforde et al., 2013) and abnormal bone mineral density (BMD) (7). To further compound 
the complexly related to the cause of injury, an individual’s genotype has also been 
associated with an increased susceptibility to stress fracture injury (8;9).  
Initial analysis of genetic associations with stress fracture prevalence in the SFEA cohort has 
shown that single-nucleotide polymorphisms (SNPs) located in the vicinity of components of 
the RANK/RANKL/OPG signalling pathway, and the P2X7 receptor are associated with stress 
fracture injuries in elite athletes and military recruits (10;11). Other SNPs, which are thought 
to control other bone regulatory pathways, in the vicinity of VDR (12), GC (13), COL1A1 (14) 
and Wnt (15) have been associated with bone phenotypes, but any association with stress 
fracture in athletes is yet to be shown. SNPs in the vicinity of genes in the Wnt signalling 
pathway, such as SOST, are particularly strong candidates to be associated with stress fracture 
injury in an athletic population, due to their suggested role in the regulation of bone 
formation, and mechanotransduction (16). While VDR SNPs have been shown to regulate of 
vitamin status, protein-protein interactions and mediate cell transcriptional factors (17).  
Therefore, the aim of the present study was determine whether 11 SNPs in the vicinity 
vitamin D, collagen and Wnt signalling pathways were associated with stress fracture injury 
in the Stress Fracture Elite Athlete (SFEA) cohort. 
Method 
A sample of 518 male (n=449) and female (n=69) elite athletes (table 1) were recruited  to 
form the Stress Fracture in Elite Athletes (SFEA) cohort. Professional athletes were classified 
as elite due to their full time participation in sport; nonprofessional athletes were classified as 
elite if they regularly competed at international or national level. Each participant completed 
a statement of informed consent and a health status questionnaire, which was followed by an 
athletic status questionnaire detailing age and playing position if applicable. Participants with 
stress fracture injuries confirmed by medical imaging (e.g., magnetic resonance imaging or 
computed tomography), were classified as cases, while those who had never experienced a 
stress fracture injury, or reported symptoms of stress fracture, were classified as controls. 
Athletes that reported to have suffered a stress fracture injury without imaging confirmation 
and those who had experienced symptoms of stress fracture injury were withdrawn from the 
analysis (n=17). Participating elite athletes competed in various sports including, football (n 
= 218), cricket (n = 156), track and field (n = 67, running events n = 62), rowing (n = 13), 
boxing (n = 2), tennis (n = 12), hockey (n = 26) and gymnastics (n = 7), with each sport 
having both stress fracture Cases and non-stress fracture Control participants. Elite athletes 
were mainly white Caucasian (83.2% in the stress fracture Cases and 79.9% in the non-stress 
fracture Controls). Ethical approval was granted by the Nottingham Trent University Ethical 
Review Committee, and each participant provided written informed consent prior to their 
involvement in the study.    
   
Sub-classifications  
Athletes were recruited from a range of sports (football, cricket, track and field, field hockey,  
gymnastics, rowing and boxing) and ranged from elite national class to Olympic medallists. 
Males, and individuals with multiple stress fractures were analysed in separate sub-
classifications due to the size of the cohort (males n=449) and the greater genetic component 
that may be present in cases of multiple stress fracture injury.   
 
Procedures 
Genotyping  
Saliva samples were collected, and genomic DNA was extracted with Norgen saliva 
collection and extraction kits  (Norgen Biotek Corp., Saliva DNA Collection Kit, Thorold, 
Canada). All procedures were conducted in accordance with manufacturers guidelines.   
SNPs were selected on the basis of their association with BMD and fragility fracture (12, 13, 
14, 15, 17, 20, 23, 26, 28) and samples were genotyped by LGC genomics (Herts, UK), who 
were blinded to the clinical status (case or control) of the genotyped individuals, using 
proprietary fluorescence-based competitive allele-specific polymerase chain reaction assay.   
 Statistical analysis   
Statistical analyses were performed using statistical package SPSS version 21.0 (SPSS Inc., 
Chicago, IL, USA). Student’s t test was used for analysis of descriptive variables. Pearson’s 
chi-squared (χ2) test was used to assess associations in genotype frequencies and to assess the 
observed frequency of each genotype with what would be expected in accordance with 
Hardy-Weinberg equilibrium. The Benjamini and Hochberg false discovery rate test was 
applied in order to account for multiple comparisons. Acceptable level of significance was 
classified as p<0.05. 
 
 
Results  
All SNPs were in accordance with Hardy Weinberg equilibrium (HWE; Supplementary table 
1.) and none of the SNPs are in linkage equilibrium.  
Stress fracture injury were recorded in 125 of the athletes that participated (Breakdown of 
stress fracture injuries by sport: Football n = 34, Cricket n = 42, running events n =27, 
Hockey n = 4, Rowing n = 5, Tennis n = 6, Boxing n = 1, gymnastics n = 4, field events n = 
2).  
Of the 11 SNPs investigated, three were significantly associated with stress fracture injury in 
one or more of the classifications (Table 2). Significant associations (p<0.05) with stress 
fracture injury were shown with SOST and VDR alleles. No differences were seen in the other 
SNPs investigated (p>0.05). 
 
Wnt Signalling     
SOST SNP rs1877632 heterozygotes were associated with stress fracture risk in the whole 
cohort, and cases of multiple stress fracture, when compared to homozygotes of the common 
allele (p<0.05; Table 3). Associations were also shown when heterozygotes were combined 
with homozygotes of the rare allele and compared to homozygotes of the common allele in 
the same classification (p<0.05). The frequency of the rare allele was greater in stress fracture 
sufferers in the whole cohort and cases of multiple stress fracture in comparison to non-stress 
fracture Control groups (p<0.05). No associations were shown when stress fracture 
occurrence was assessed with either LRP5 SNP rs3736228 or Wnt16 SNP rs3801387 
genotypes (p>0.05).   
 
Vitamin D SNPs 
An association between VDR SNP rs10735810 and increased occurrence of multiple stress 
fracture injury was shown in homozygotes of the rare f allele, when compared to 
homozygotes of the common allele combined with heterozygotes (p<0.05; Table 3). Stress 
fracture occurrence was associated with the frequency of the rare allele in cases of multiple 
stress fracture and in male athletes (p<0.05). Those with at least one copy of the rare allele of 
rs731236 had a greater stress fracture occurrence in cases of multiple stress fractures (p<0.05). 
No significant associations were shown between VDR SNPs rs1544410 and rs79752321, GC 
SNPs rs7041and rs4588, CTR SNP rs1801197 and COL1A1 SNP rs1800012 and stress 
fracture occurrence (p>0.05).    
After correcting for multiple comparisons, using the Benjamini and Hochberg false discovery 
rate test, none of the associations above remained significant. 
 
Discussion 
 
The present study shows that three novel SNPs, in close proximity to SOST and VDR genes, 
were associated with stress fracture injury in elite athletes. The sclerostin encoding SOST 
SNP rs1877632, suggested to have a role in the functioning of the Wnt signalling pathway 
(15), was associated with stress fracture injury in elite athletes, and in cases of multiple stress 
fracture. The Wnt signalling pathway is a predominant regulator of bone metabolism, having 
a role in the mediation of the differentiation and longevity of osteoblasts, thus positively 
affecting bone formation (18). The purported role of VDR SNPs in the mediation of vitamin 
D status (17) and transcription activation characteristics of the VDR protein (19) may be 
causative factors in the aetiology of stress fracture injury.  
 
The current study’s finding, shows for the first time that SOST SNP rs1877632 is associated 
with stress fracture injury and is in accordance with previous research showing associations 
between SOST SNPs and bone phenotypes including, sclerosteosis (20) and BMD at the 
lumbar spine (15) and femoral neck (17). That said, the A allele was associated with 
increased stress fracture risk in the present study, whereas previous research (15) has shown 
that A allele homozygotes were associated with increased BMD at the lumbar spine in a large 
cohort of elderly male participants. Dissimilarity in phenotypic and lifestyle characteristics of 
elite athletes and elderly males make it difficult to directly compare the findings; moreover a 
reduction in bone formation as a result of ageing has recently been suggested to be due to 
insufficient Wnt activity in response to mechanical loading (20), thus explaining a potential 
mechanistic reason for these contrasting associations. The mechanisms underlying the 
increased stress fracture risk in those with the variant A allele are not known, although allelic 
variation in SOST SNPs has been associated with serum sclerostin levels (21) and SOST null 
mice have increased bone formation compared to their wild-type counterparts (23). It is 
possible that the rare allele of rs1877632 down regulates sclerostin expression, and, as 
sclerostin inhibits Wnt signalling (24), this could result in an increased susceptibility to stress 
fracture injury due to a reduction in bone formation. 
 
The elite athletes in the present study were all competing in weight bearing sports, such 
participation been associated with high levels of sclerostin (25). The reason for the greater 
sclerostin concentrations in the athlete population could be due to the increased number of 
sclerostin expressing osteocytes located within an athletes’ bone mineral compared to a non-
athletes (26). Currently, the effect of repeated mechanical loading has on SOST expression 
has been equivocal, but somewhat paradoxically, it has been shown that osteocyte SOST 
expression is down regulated during exercise (27). This suggests that there may be a 
mechanostransductive element of sclerostin mediation, and changes in levels of sclerostin act 
through a negative feedback loop to limit ‘excessive’ increases in bone formation as the result 
of high volume loading (26). Therefore, the habitual high volume and high magnitude 
mechanical loading that elite athletes encounter may result in transient increases in sclerostin 
concentrations (25) which, combined with the SNP rs1877632 genotype, may be the reason 
for the increase in stress fracture susceptibility.  
 
VDR SNPs rs731236 and rs10735810 were significantly associated with stress fracture injury 
in the whole cohort, in males, and in cases of multiple stress fracture. The present data in elite 
athletes showing the variant allele of rs10735810 to be associated with stress fracture injury 
is in line with previous research in military personnel (9). The confirmation of this SNPs role 
in stress fracture injury in a separate population that experience different exercise demands, 
may underline its important role in bone homeostasis and suggests the need for further 
investigation into the role of this SNPs in the repair and maintenance of bone tissue.        
 
The variant allele of rs731236 was associated with stress fracture injury in cases of multiple 
stress fractures. Previous studies have shown the rare allele of rs731236 to be associated with 
decreased bone phenotypes consisting mainly of trabecular bone (12). Despite showing some 
agreement with previous research, the role of the VDR gene in bone homeostasis and stress 
fracture prevalence is contentious due to seemingly divergent findings. The absence of any 
VDR SNPs consistently associated with bone phenotypes in GWAS studies suggest the VDR 
SNPs could be a proxy for other functional SNPs, and/or the associations are restricted to 
certain populations (28). Also, the majority of the candidate gene studies focusing on VDR 
can be characterised by relatively small cohorts, which is particularly the case in those 
investigating the association with stress fracture prevalence (n=64, 9; n=192, 8), increasing 
the likelihood of false positives. Although the mechanisms by which VDR SNPs influence 
stress fracture risk remain unclear, the binding of the VDR to 1,25(OH)2D induces absorption 
of calcium and phosphate for bone mineralisation and homeostatic metabolism (27). 
Mutations in VDR cause vitamin D-resistant rickets, characterised by increased risk of 
fracture and genu varum (Kristjansson et al., 1993), due to insufficient absorption of calcium 
and phosphate by the intestine rather than a direct influence on 1,25(OH)2D3 concentrations 
(Ralston and de Crombrugghe, 2006). McClung and Karl (2010) suggest that allelic variation 
in polymorphisms within the VDR gene can increase the concentration of 1,25(OH)2D, which 
may facilitate bone health and therefore reduce the risk of bone injury.  VDR null mice have 
low bone mass characterised by hypocalcaemia, as well as elevated 1,25(OH)2D3 levels, 
while VDR activity has been shown to influence RANKL expression (29), thus offering 
possible mechanistic explanations for the associations shown. 
  
The number of SNPs showing an association with stress fracture injury in the SFEA cohort 
(10;11) and in previous research (8;9) highlights the likely complexity of stress fracture 
aetiology. Alterations in bone remodelling, and mechanotransductive responses to 
mechanical loading are two plausible explanations for the associations. GWAS have shown 
two main biological pathways to be related to bone mineral density and fragility fracture (28); 
the RANK/RANKL/OPG signalling pathway and the Wnt-signalling pathway. The majority of 
SNPs associated with stress fracture prevalence in the present study are either directly related 
to or have a downstream influence on these pathways, adding substantiation to their role as 
major regulatory pathways in bone health.   
 
 
Although the SFEA cohort is the largest to be studied for genetic associations with stress 
fracture prevalence to date, it is not without its limitations. Whilst heterogeneity in ethnicity, 
sport type, training loads/stresses and environmental factors (e.g., nutrition/energy 
availability) are acknowledged as variable factors in the present study, these factors are 
currently unavoidable given the low number of elite athletes available to participate in such 
studies and the difficulty in recruiting participants due to perceived disruption of training 
schedules. Investigations into large numbers of single sport athletes is recommended to 
confirm our findings, however divergent playing styles and positions with sports make this a 
challenging undertaking. After correcting for multiple comparisons none of the findings 
remained significant. However, the SNPs were not randomly selected, and were selected 
based on existing evidence of a bone phenotypic association with known mechanisms 
supporting their potential role in stress fracture injury. The conservative nature and problems 
with conducting multiple comparison testing (30) increase the chances of a type two error 
occurring. We are confident that a type II error is unlikely to have occurred in the present 
study as the direction of the effect is consistent with previously published data related to bone 
phenotypes. If the findings were to have occurred by chance, effects in different directions 
would be expected. Further studies are needed to establish the underpinning mechanisms that 
explain how SNPs are associated with stress fracture injury as it is not clear how allelic 
variations influence bone adaptations and subsequently escalate stress fracture risk.    
 
In conclusion, SNPs in the vicinity of VDR and the Wnt signalling pathways are associated 
with increased stress fracture prevalence in elite athletes. These data suggest an important 
role for SNPs in stress fracture susceptibility, possibility through the regulation of bone 
adaptation to mechanical loading.  
Practical implications 
 Elite athletes with particular genetic variances may have an increased susceptibility to 
stress fracture injury.  
 Knowledge related to the SOST and VDR pathways and there implications for bone 
health may be of use to sport and exercise practitioners in the multifaceted 
management, treatment and prevention of stress fracture injury.  
 The findings suggest that genetic regulators of bone adaptation to mechanical loading 
are key to stress fracture injury pathophysiology. This should be considered when 
managing an athlete’s training load. 
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Table 1. Athlete characteristics for stress fracture and non-stress fracture groups.  
 Characteristics 
Stress fracture 
(n=125) 
Non-stress 
fracture 
(n=376)  
P-value  
Age (y) 27.7±7.5 24.4±5.4 <0.01* 
Age at stress fracture (y)       19.9±3.9 -  
Height (m) 1.82±0.10 1.81±0.08 0.45 
Body Mass(kg) 77.3±14.5 77.8±10.5 0.72 
BMI 23.2±2.7 23.7±2.2 0.07 
Age at elite (y) 18.2+4.2 17±2.2 <0.01* 
Current Training (h/wk) 20±11.3 18.2±10.1 0.12 
Current alcohol 
consumption (units/wk) 
5.2±6.9 4.1±6.1 0.15 
    * was used to denote significance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Association of SNPs with stress fracture injury in elite athletes for the whole cohort, males and multiple stress fractures. (Gene) = 
closest gene; (p) = p value; (Homo) = homozygote for the variant allele; (Combined with Heterozygote) = homozygote for the variant allele 
combine with heterozygote; (AF) = allele frequency. 
 
    
Whole cohort (n = 518). P values Males (n = 449). P values  
Multiple Stress Fractures (n= 49). 
P values 
RS Number Location Gene Homo 
Combined  with 
Heterozygote AF Homo 
Combined 
with 
Heterozygote AF Homo 
Combined 
with 
Heterozygote AF 
rs1544410 12q13.11 VDR 0.46 0.27 0.44 0.39 0.26 0.51 0.10 0.11 0.47  
rs731236 12q13.11 VDR 0.50 0.36 0.61 0.45 0.53 0.97 0.01* 0.21 0.21  
rs7975232 12q13.11 VDR 0.62 0.54 0.92 0.39 0.28 0.64 0.50 0.97 0.52  
rs10735810 12q13.11 VDR 0.17 0.20 0.03* 0.35 0.62 0.21 0.01* 0.00* 0.02*  
rs7041 4q12-q13 GC 0.50 0.99 0.84 0.71 0.84 0.74 0.53 0.32 0.21  
rs4588  4q12-q14 GC 0.31 0.22 0.39 0.65 0.09 0.18 0.88 0.88 0.95  
rs1801197 7q21.3 CTR 0.72 0.74 0.48 0.57 0.53 0.30 0.99 0.88 0.87  
rs1800012 17q21.33 COL1A1 0.38 0.93 0.57 0.67 0.96 0.81 0.33 0.61 0.94  
rs3801387 7q31.31 WNT16 0.30 0.45 0.14 0.30 0.29 0.09 0.62 0.40 0.31  
rs1877632 17q11.2 SOST 0.05* 0.02* 0.04* 0.28 0.12 0.11 0.05* 0.02* 0.05*  
rs3736228 11q13.4 LRP5 0.46 0.27 0.44 0.82 0.73 0.75 0.10 0.11 0.47  
* depicts significant differences (p<0.05). 
       
Table 3. Distribution of genotypes between stress fracture and non-stress fracture participants 
for SNPs showing significant associations in the whole cohort, males only or multiple stress 
fracture.  
SNP 
 
Stress 
fracture N  
Non-stress 
fracture N  
X2 P value 
 
Stress 
fracture N 
       
Non-stress  
fracture N 
                        X2 P value          
Whole cohort 
      VDR rs10735810 
       
         
 
FF 49 169  F 148 483 
 
 
Ff 50 145  f 90 221 
 
 
ff 20 38  Total 238 704 0.3 
 
Total 119 352 0.17 
   
       
  VDR rs731236 
  
 
    
tt 13 46  t 87 260 
 
Tt 61 168  T 141 452 
 
TT 40 142  Total 228 712 0.61 
Total 114 356 0.50 
    
   
 
    SOST  rs1877632 
  
 
    CC 50 191  C 159 513 
 TC 59 131  T 85 207 
 TT 13 38  Total 244 720 0.04* 
Total 122 360 0.05* 
            
Male 
  
 
    VDR rs10735810 
  
 
    
 
FF 42 150  F 120 429 
 
 
Ff 36 129  f 66 195 
 
 
ff 15 33  Total 186 624 0.21 
 
Total 93 312 0.35 
    
 
       
 
VDR rs731236 
  
 
    
 
tt 9 43  t 66 235 
 
 
Tt 48 149  T 112 401 
 
 
TT 32 126  Total 178 636 0.97 
 
Total 89 318 0.45 
    
       
SOST  rs1877632   
  
 
    
 
CC 43 172  C 128 458 
 
 
TC 42 114  T 64 180 
 
 
TT 11 33  Total 192 638 0.11 
 
Total 96 319 0.28 
    
       
 
Multiple stress fractures  
    VDR rs10735810 
  
 
    
 
FF 14 169  F 49 483 
 
 
Ff 21 145  f 45 221 
 
 
ff 12 38  Total 94 704 0.02* 
 
Total 47 352 0.01* 
    
    
 
    VDR rs731236 
  
 
    
 
tt 3 46  t 37 260 
 
 
Tt 31 168  T 49 452 
 
 
TT 9 142  Total 86 712 0.21 
 Total 43 356 0.01* 
    
SOST  rs1877632 
  
 
    
 
 
CC 15 175  C 58 493 
 
 
TC 28 143  T 40 229 
 
 
TT 6 43  Total 98 722 0.05* 
 
Total 49 361 0.05* 
    * depicts significant differences (p<0.05). Values have not been adjusted for multiple comparisons.    
         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
